
The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3d1SeBV
via
IFTTT
0 comments:
Post a Comment